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The title molecule is shown in Fig 
S2. Experimental
The title compound was synthesized according to the published procedure (Vaarla & Rao, 2014) . The compound was synthesized in two steps. In step one, a mixture containing equivalent amounts of 5-methylisoxazole-3-carboxylic acid and 4-amino-4H-[1,2,4]triazole-3,5-dithiol was refluxed in the presence of phosphorus oxychloride for about 5 h. After monitoring by TLC, the reaction mixture was cooled to room temperature and poured into crushed ice. The separated solid was filtered, dried and recrystallized from methanol.
In the second step the intermediate 6- ,3,4] thiadiazole-3-thiol (1 eq.) was treated with benzyl bromide (1.1 eq.) in ethanol. The reaction mixture was refluxed for 5 h. After completion of the reaction, the reaction mixture was cooled to room temperature. The isolated solid product was filtered and washed with ethanol. Recrystallization was from ethanol.
S3. Refinement
All H atoms were placed in calculated positions with C-H = 0.93 to 0.97 Å, refined in the riding model with U iso (H) parameters set to 1.2U eq (C) or 1.5U eq (CH 3 only). The (0 0 -2), (2 0 1) and (2 0 0) reflections, whose intensities were
affected by the beamstop, were removed from the final refinement.
Figure 1
The title molecule with the atom numbering scheme. Displacement ellipsoids for non-H atoms are drawn at the 30% probability level.
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Figure 2
View of the molecular packing of the title compound down the b axis. All H atoms have been omitted for clarity. 2 ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
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